Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Quarterly Statistics: Anthos, Gossamer Lead Q1 Financings; Codiak/Jazz Deal Tops Alliances

Executive Summary

In a review of biopharma start-up dealmaking and financing activity from January through March, based on data from Strategic Transactions, Anthos completed the largest venture capital round in the first quarter, raising $250m.

Advertisement

Related Content

Poseida's CAR-T, Gene Therapy Programs Get $142m Boost, Including Novartis Cash
Hijacking The Messenger
Asia Deal Watch: Takeda On A Deal Spree
Deal Watch: Celgene Joins Line Of Partners Tapping Exscientia’s AI-Driven Discovery Engine
Pfizer Buys Option For Vivet In Latest Gene Therapy Tie-Up
Finance Watch: VC Mega-Deals Launch Biopharma Firms With New Takes On CV, Genetic Diseases
Deal Watch: Novartis Opts In On Lipoprotein A Candidate From Akcea
Deal Watch: Xencor Adds New Bispecific Partner In Agreement With Genentech
Deal Watch: Cancer Remains Hot Target At J.P. Morgan
Finance Watch: Former Juno Execs Launch Sana With Allogeneic Cell Therapy Platform

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC125154

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel